<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND/AIMS: Recent evidence indicates that reactive oxygen species (ROS) can induce a wide type of cellular responses from proliferation to senescence and cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>ROS may not be an absolute carcinogenic factor or <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> suppressor </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this study was to assess the biological paradox of ROS in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells </plain></SENT>
<SENT sid="3" pm="."><plain>METHODOLOGY: Blood specimens were obtained from the drainage vein of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> during operation in 135 patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Serum ROS levels were measured using the derivatives of reactive oxygen metabolites (d-ROM) test </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Serum ROS levels increased significantly in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size larger than 40mm (p&lt;0.01) </plain></SENT>
<SENT sid="6" pm="."><plain>On the other hand, serum ROS levels decreased significantly in patients with lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (p&lt;0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>Multiple linear regression models showed a significant association of serum ROS levels with serum carcinoembryonic antigen (CEA) levels (p&lt;0.01) and lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (p=0.026) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: In <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells, the increase of intracellular ROS is first associated with cell growth and invasion </plain></SENT>
<SENT sid="9" pm="."><plain>However, a further increase inhibits <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell proliferation, whereas any decrease in ROS concentration needs to stimulate lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>Thus, a precise understanding how ROS are generated and involved in lymph node <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> will help us to design better therapeutic strategies </plain></SENT>
</text></document>